Curated News
By: NewsRamp Editorial Staff
April 23, 2025
BioRestorative Therapies CEO Shares Vision for Stem Cell Therapies to Combat Chronic Pain and Metabolic Diseases
TLDR
- BioRestorative Therapies develops innovative stem cell therapies to tackle chronic back pain, obesity, and diabetes, giving them a competitive edge in regenerative medicine.
- The company's flagship program, BRTX-100, and ThermoStem® use stem cells to target chronic back pain and metabolic diseases, respectively, in phase 2 clinical trials.
- BioRestorative Therapies' focus on alleviating chronic pain and diseases through stem cell therapies offers hope to millions worldwide, improving their quality of life.
- Check out Lance Alstodt's interview on Benzinga's All-Access to learn more about BioRestorative Therapies' cutting-edge regenerative medicine approach.
Impact - Why it Matters
This news matters as it highlights innovative stem cell therapies being developed to tackle prevalent health issues. By utilizing stem cells to address chronic pain and metabolic diseases, BioRestorative Therapies is offering potential solutions to improve the lives of millions worldwide.
Summary
Lance Alstodt, CEO of BioRestorative Therapies, discusses the company's mission to address chronic lower back pain, obesity, and diabetes through stem cell therapies. Their flagship program, BRTX-100, is in a phase 2 clinical trial to alleviate back pain using a patient's own stem cells. ThermoStem® targets metabolic diseases like obesity and type 2 diabetes by generating new brown fat tissue.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, BioRestorative Therapies CEO Shares Vision for Stem Cell Therapies to Combat Chronic Pain and Metabolic Diseases
